COVID-19 Variant Supplement – Improving Outcomes in Individuals with COVID‑19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial
Liu, Peter P |
Ottawa Heart Institute Research Corporation | Operating Grant | $50,000
CIHR Ontario 2021
Read More